Table 3 |
||||
|
Clinical Outcomes: Summary of tumor response by RESIST criteria. |
||||
|
3A |
||||
|
|
||||
|
N-patients |
Number of Patients (%) |
|||
|
|
||||
|
Complete Response |
9 (64.3%) |
|||
|
|
||||
|
Partial Response |
1 (7.1%) |
|||
|
|
||||
|
Stable Disease |
1 (7.1%) |
|||
|
|
||||
|
Progressed Disease |
3 (21.4%) |
|||
|
|
||||
|
N+ patients |
||||
|
|
||||
|
Complete Response |
1 (12.5%) |
|||
|
|
||||
|
Progressed Disease |
7 (87.5%) |
|||
|
|
||||
|
3B |
||||
|
|
||||
|
Clinical Stage |
Complete Response |
Partial Response |
Stable Disease |
Progressed Disease |
|
|
||||
|
rT0N1M0 |
1 |
|||
|
|
||||
|
rT0N0M1 |
1 |
|||
|
|
||||
|
rT2N0M0 |
3 |
|||
|
|
||||
|
rT3N0M0 |
3 |
1 |
1 |
|
|
|
||||
|
rT3N1M0 |
2 |
|||
|
|
||||
|
rT3N2M0 |
1 |
|||
|
|
||||
|
rT4N0M0 |
3 |
2 |
||
|
|
||||
|
rT4N1M0 |
2 |
|||
|
|
||||
|
rT4N2M0 |
2 |
|||
|
|
||||
|
(A) Tumor response for patients without lymph node metastases (N-) and for patients with lymph node metastases (N+). (B) Tumor response based on clinical stage. |
||||
|
Kawaguchi et al. Radiation Oncology 2010 5:51 doi:10.1186/1748-717X-5-51 |
||||
